Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Icad Inc (ICAD)

Icad Inc (ICAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
iCAD, Inc. Showcases AI-Powered Breast Health Innovations and Partnership with Cascaid Health at RSNA 2024

iCAD will present AI-driven breast health solutions at RSNA 2024, showcasing new technology and partnerships to improve cancer detection.Quiver AI SummaryiCAD, Inc., a leading provider of AI-powered cancer...

ICAD : 1.7300 (+9.49%)
iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024

ICAD : 1.7300 (+9.49%)
Icad: Q3 Earnings Snapshot

Icad: Q3 Earnings Snapshot

ICAD : 1.7300 (+9.49%)
iCAD Reports Financial Results for Third Quarter Ended September 30, 2024

ICAD : 1.7300 (+9.49%)
iCAD's ProFound Detection Version 4.0 Gains FDA Clearance

ICAD : 1.7300 (+9.49%)
iCAD to Attend 15th Annual Craig-Hallum Alpha Select Conference

ICAD : 1.7300 (+9.49%)
iCAD to Report Third Quarter 2024 Financial Results on November 13, 2024

ICAD : 1.7300 (+9.49%)
iCAD to Participate in the LD Micro Main Event XVII

Nashua, New Hampshire--(Newsfile Corp. - October 16, 2024) - iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can't hide by providing clinically...

ICAD : 1.7300 (+9.49%)
iCAD Highlights Global Availability of ProFound Cloud and International Expansion Milestones at JFR 2024

ICAD : 1.7300 (+9.49%)
Icad: Q2 Earnings Snapshot

Icad: Q2 Earnings Snapshot

ICAD : 1.7300 (+9.49%)

Barchart Exclusives

This Dividend Stock Yielding 5% Hasn't Made Money for Buffett, But Could It Work for You?
Kraft-Heinz has not made money for Warren Buffett for almost a decade, since the merged entity started trading. Should you bet on the stock for its 5% dividend yield? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar